We are live on
!
Find out more
PM
Penbrook Management Portfolio holdings
AUM
$157M
1-Year Est. Return
46.57%
This Fund
S&P 500
This Quarter
Est. Return
+1.87%
1 Year Est. Return
+46.57%
3 Year Est. Return
+105.97%
5 Year Est. Return
+154.19%
10 Year Est. Return
–
AUM
$105M
AUM Growth
-$7.28M
(-6.5%)
Cap. Flow
-$7.72M
Cap. Flow
% of AUM
-7.33%
Top 10 Holdings %
Top 10 Hldgs %
26.55%
Holding
118
New
2
Increased
12
Reduced
41
Closed
12
Avg Time Held
4.9
quarters
Top 10 Avg Time Held
2.4
quarters
Top 20 Avg Time Held
3.2
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATLAS RESOURCE PARTNERS L P COM UIT REPSTG LTD PTNRS
ARP
|
+$939K |
| 2 |
LMRK
Landmark Infrastructure Partners LP Common Units
LMRK
|
+$519K |
| 3 |
AGN
Allergan plc
AGN
|
+$315K |
| 4 |
VivoSim Labs
VIVS
|
+$238K |
| 5 |
Navigator Holdings
NVGS
|
+$130K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Harvard Bioscience
HBIO
|
+$1.62M |
| 2 |
CALL
magicJack VocalTec Ltd
CALL
|
+$938K |
| 3 |
VTSS
VITESSE SEMICONDUCTOR CORPORATION COMMON STOCK
VTSS
|
+$933K |
| 4 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$829K |
| 5 |
AFFX
Affymetrix Inc
AFFX
|
+$802K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.52% |
| 2 | Healthcare | 14.97% |
| 3 | Miscellaneous | 13.49% |
| 4 | Financials | 10.99% |
| 5 | Energy | 10.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Cisco
CSCO
$456B
| $853K | 0.81% |
31,050
| – | – |
2013 Q4
6 quarters
|
|
52
Berkshire Hathaway Class B
BRK.B
$1.11T
| $851K | 0.81% |
6,250
-250
| -4% | -$35.7K |
2013 Q4
6 quarters
|
|
53
Baytex Energy
BTE
$3.41B
| $851K | 0.81% |
54,603
| – | – |
2013 Q4
6 quarters
|
|
|
MIN
54
Aberdeen Intermediate Income Fund
MIN
$262M
| $845K | 0.8% |
30,476
-666
| -2% | -$19.1K |
2013 Q4
6 quarters
|
|
55
Itron
ITRI
$3.77B
| $834K | 0.79% |
24,225
| – | – |
2015 Q1
1 quarter
|
|
56
Eaton Vance Tax-Advantaged Dividend Income Fund
EVT
$2.09B
| $803K | 0.76% |
40,566
-6,800
| -14% | -$140K |
2013 Q4
6 quarters
|
|
57
Nuveen New York Municipal Value Fund
NNY
$152M
| $766K | 0.73% |
79,000
| – | – |
2013 Q4
6 quarters
|
|
|
58
Harvard Bioscience
HBIO
$38.7M
| $741K | 0.7% |
12,995
-28,510
| -69% | -$1.62M |
2013 Q4
6 quarters
|
|
59
Lightpath Technologies
LPTH
$628M
| $732K | 0.7% |
415,707
| – | – |
2013 Q4
6 quarters
|
|
60
Global Partners
GLP
$1.67B
| $702K | 0.67% |
21,653
| – | – |
2013 Q4
6 quarters
|
|
61
Sony
SONY
$142B
| $698K | 0.66% |
123,000
-3,000
| -2% | -$18.4K |
2013 Q4
6 quarters
|
|
|
62
VivoSim Labs
VIVS
$2.34M
| $658K | 0.62% |
727
+213
| +41% | +$238K |
2013 Q4
6 quarters
|
|
|
SEAC
63
DELISTED
Seachange International Inc
SEAC
| $601K | 0.57% |
4,290
-250
| -6% | -$35.3K |
2013 Q4
6 quarters
|
|
64
Fiserv Inc
FISV
$24.5B
| $595K | 0.57% |
14,368
-5,400
| -27% | -$217K |
2013 Q4
6 quarters
|
|
65
NGL Energy Partners
NGL
$1.83B
| $591K | 0.56% |
19,500
| – | – |
2014 Q3
3 quarters
|
|
|
TWX
66
DELISTED
Time Warner Inc
TWX
| $577K | 0.55% |
6,602
-100
| -1% | -$8.53K |
2013 Q4
6 quarters
|
|
67
Chegg
CHGG
$79.4M
| $572K | 0.54% |
72,950
| – | – |
2014 Q2
4 quarters
|
|
68
Travel + Leisure Co
TNL
$3.81B
| $564K | 0.54% |
15,259
| – | – |
2013 Q4
6 quarters
|
|
69
DELISTED
Legacy Reserves Inc. Common Stock
LGCY
| $551K | 0.52% |
64,240
+2,000
| +3% | +$22K |
2013 Q4
6 quarters
|
|
70
Novartis
NVS
$273B
| $541K | 0.51% |
6,138
+335
| +6% | +$30.7K |
2013 Q4
6 quarters
|
|
71
DELISTED
Veren
VRN
| $535K | 0.51% |
26,383
-445
| -2% | -$10.4K |
2014 Q3
3 quarters
|
|
72
First Bancorp
FBP
$4.11B
| $530K | 0.5% |
109,860
-1,140
| -1% | -$7.19K |
2013 Q4
6 quarters
|
|
73
Marchex
MCHX
$57.2M
| $528K | 0.5% |
106,650
| – | – |
2013 Q4
6 quarters
|
|
|
LMRK
74
DELISTED
Landmark Infrastructure Partners LP Common Units
LMRK
| $491K | 0.47% |
+30,400
| New | +$519K |
2015 Q2
0 quarters
|
|
75
Power Integrations
POWI
$2.65B
| $470K | 0.45% |
20,800
-200
| -1% | -$5K |
2013 Q4
6 quarters
|
|
Similar funds
AFW
QGA
AWA
BGAI
AIG
MFG
BCM
MCM
Penbrook Management's Q2 2015 Portfolio in Review
As of Q2 2015, Penbrook Management held 118 positions worth $105M, down 6.5% from $113M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Penbrook Management withdrew a net $7.72M in Q2 2015, closing 12 positions and reducing 41 holdings. Its most notable exit was magicJack VocalTec Ltd, an estimated $938K position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Healthcare and Miscellaneous.
Against the trend, Penbrook Management opened a new position in Landmark Infrastructure Partners LP Common Units worth $491K.
- Penbrook Management's largest Q2 2015 buy was Landmark Infrastructure Partners LP Common Units: 30,400 shares worth $491K.
- Penbrook Management added most to ATLAS RESOURCE PARTNERS L P COM UIT REPSTG LTD PTNRS in Q2 2015, an estimated $939K increase.
- Penbrook Management's biggest Q2 2015 reduction was Harvard Bioscience, cutting an estimated $1.62M.
- Penbrook Management fully exited magicJack VocalTec Ltd in Q2 2015, selling an estimated $938K.
- Penbrook Management's ten largest holdings make up 27% of its $105M portfolio in Q2 2015.
- Penbrook Management opened 2 new positions and closed 12 in Q2 2015.
- Penbrook Management's portfolio value fell 6.5% quarter-over-quarter to $105M.
Based on Penbrook Management's 13F filing for Q2 2015, filed 4 Aug 2015.